Login to Your Account



Analyst: Expect Active Year in Deal-Making

Kosan's Cancer Pipeline Attracts $5.50 Per Share BMS Buyout Bid

By Jennifer Boggs


Friday, May 30, 2008
Kosan Biosciences Inc. is being snatched up by Bristol-Myers Squibb Co. for $5.50 per share, becoming the latest acquisition as big pharma struggles to fill dwindling pipelines. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription